More good news for #ShockwaveC2, the Centers for Medicare and Medicaid Services (CMS) has proposed a New Technology Add-on Payment (NTAP) for #CoronaryIVL in the proposed FY2022 hospital inpatient rule.
Read the Press Release: https://t.co/ABhLYwFICn
ISI https://t.co/bzsYN47Xjc
We’ve finally cracked it! Coronary #ShockwaveIVL is now FDA approved in the United States! Reach out to your rep today to get #ShockwaveC2 in your cath lab. Don't know your local rep yet? We'll put you in touch.
https://t.co/NPY0lnH3W8
ISI https://t.co/bzsYN47Xjc #CardioTwitter
See the four new HCPCS codes for #ShockwaveIVL outpatient procedures performed #BTK! Check out all the reimbursement updates – including new coding & sites of service – for peripheral #IVL starting Jan 1, 2021.
https://t.co/rzgFuLyXLJ
ISI https://t.co/Q2peu4kDd6 #CardioTwitter
@SuzanneWallac15 You are the best! Wish I could have joined you for this (and not just because of the drinks 😜) I’d be more sad if I thought we wouldn’t stay in touch 👊
Read the Q&A with Dr. @sahilparikhmd, corresponding author on the @CCIJournal Peripheral #ShockwaveIVL Meta-Analysis Publication, on the outcomes of the patient-level meta-analysis and importance of the results.
ISI https://t.co/Q2peu4kDd6 #CardioTwitter
https://t.co/lX7LPNxqKk
Tune in tomorrow at 7PM ET! Learn about #ShockwaveIVL for #EVAR/#TEVAR Access & #Iliac Occlusive Disease in the @EVToday webinar featuring Drs @FrankArko1 @FotehMazinMD @ehrin_armstrong & Prof Andrew Holden.
Register today: https://t.co/hakZkmLLHR
ISI https://t.co/Q2peu4kDd6
The Peripheral #IVL Meta-Analysis has been published in @CCIJournal! It combines results of 5 peripheral #ShockwaveIVL studies including 336 patients, confirming the safety & efficacy of IVL across all peripheral vessels. https://t.co/kwA9Rwqny0
ISI https://t.co/Q2peu4kDd6